Showing results (161-170 of 354) with videos related to

Sort By:
Pageof 36
Frontiers in Oncology|June 6, 2022
A Lung Cancer Patient Harboring a Rare Oncogenic EGFR Exon 20 V786M Mutation Responded to a Third-Generation Tyrosine Kinase Inhibitor: Case Report and Review of the LiteratureQi Zhu, Mingyun Jiang, Wenfei Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2008
FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's diseaseRob Barker, Fahrad Kazmi, Justin Stebbing, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2009
The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignanciesBelinda Lee, Ingrid Franklin, Jacqueline S Lewis, et al.
Cancer Letters|January 8, 2016
LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5Jimmy Jacob, Rosy Favicchio, Negin Karimian, et al.
BMC Medical Genomics|April 16, 2024
An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinomaZhonghai Du, Xiuchen Han, Liping Zhu, et al.
Experimental Biology and Medicine (Maywood, N.J.)|September 3, 2013
Stem cells of the lower limb: their role and potential in management of critical limb ischemiaColin A Hart, Janice Tsui, Achal Khanna, et al.
Oncotarget|April 7, 2016
ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradationJoao Nunes, Hua Zhang, Nicos Angelopoulos, et al.
The Journal of Antimicrobial Chemotherapy|May 25, 2005
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterolVictoria Latham, Justin Stebbing, Sundhiya Mandalia, et al.
Expert Review of Molecular Diagnostics|October 17, 2013
Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
Oncology Research and Treatment|February 3, 2022
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-AnalysisLing Peng, Bao-Dong Qin, Song Xu, et al.
Pageof 36